Clinical Trials Logo

Clinical Trial Summary

The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02454803
Study type Observational
Source Ipsen
Contact
Status Completed
Phase
Start date January 2015
Completion date June 3, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04936542 - A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. Phase 4
Completed NCT00945295 - Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity N/A
Active, not recruiting NCT05956509 - Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity Phase 1/Phase 2
Completed NCT00465738 - IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity Phase 3
Completed NCT02321436 - Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Phase 4
Completed NCT00430196 - BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity Phase 4
Completed NCT03821402 - Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity Phase 2
Terminated NCT02888548 - Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox) N/A
Completed NCT01863901 - Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device N/A